Avidity Biosciences Ownership | Who Owns Avidity Biosciences?
Avidity Biosciences Ownership Summary
Avidity Biosciences is owned by 32.09% institutional investors, 5.18% insiders, and 62.73% retail investors. Fmr is the largest institutional shareholder, holding 13.38% of RNA shares. Fidelity Growth Compy Commingled Pl S is the top mutual fund, with 4.22% of its assets in Avidity Biosciences shares.
RNA Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Avidity Biosciences | 32.09% | 5.18% | 62.73% |
| Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
| Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 16.51M | 13.38% | $480.10M |
| Rtw investments, lp | 8.81M | 10.10% | $359.76M |
| Blackrock | 8.62M | 9.89% | $352.23M |
| Price t rowe associates inc /md/ | 11.04M | 8.95% | $321.13M |
| Blackrock funding, inc. /de | 9.93M | 8.05% | $288.83M |
| Vanguard group | 9.43M | 7.64% | $274.28M |
| Wellington management group llp | 8.11M | 6.57% | $235.73M |
| Avoro capital advisors | 7.50M | 6.08% | $218.10M |
| Janus henderson group | 7.05M | 5.72% | $205.13M |
| Ra capital management | 6.30M | 5.11% | $183.22M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Alethea capital management | 420.87K | 10.48% | $12.24M |
| Rtw investments, lp | 8.81M | 5.57% | $359.76M |
| Propel bio management | 178.50K | 5.16% | $5.19M |
| Casdin capital | 2.04M | 3.96% | $59.47M |
| Boxer capital | 1.73M | 3.72% | $70.56M |
| Silverarc capital management | 543.65K | 3.46% | $15.81M |
| Avoro capital advisors | 7.50M | 3.08% | $218.10M |
| Bioimpact capital | 702.98K | 2.90% | $20.44M |
| Ra capital management | 6.30M | 2.44% | $183.22M |
| Cormorant asset management, lp | 1.05M | 1.68% | $30.53M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 8.62M | 0.01% | 2.46M |
| Janus henderson group | 7.05M | 0.10% | 2.16M |
| Polar capital | 1.11M | 0.27% | 1.11M |
| Wellington management group llp | 8.11M | 0.04% | 1.08M |
| Rtw investments, lp | 8.81M | 5.57% | 836.57K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Cowen and company | - | - | -5.13M |
| Nuveen asset management | 352.50K | 0.00% | -706.06K |
| 5am venture management | - | - | -665.55K |
| D. e. shaw | 558.97K | 0.01% | -549.68K |
| Lord, abbett | - | - | -539.21K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Polar capital | 1.11M | 0.27% | 1.11M | $45.51M |
| Norges bank | 724.79K | 0.00% | 724.79K | $21.08M |
| Artal group | 655.55K | 0.68% | 655.55K | $26.78M |
| Finepoint capital lp | 391.30K | 0.69% | 391.30K | $11.38M |
| Qube research | 223.76K | 0.01% | 223.76K | $6.51M |
Sold Out
| Holder | Change |
|---|---|
| Ronald blue trust | -8.00 |
| Hollencrest capital management | -10.00 |
| Park place capital | -12.00 |
| Nelson, van denburg & campbell wealth management group | -15.00 |
| Capital performance advisors llp | -21.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 106 | -57.77% | 39,596,419 | -68.40% | 32 | 0.31% | 62 | -60.00% | 30 | -52.38% |
| Sep 30, 2024 | 250 | 26.26% | 125,295,284 | 11.90% | 101 | 0.62% | 154 | 19.38% | 63 | 28.57% |
| Jun 30, 2024 | 198 | 22.98% | 111,975,611 | 25.39% | 128 | 1.22% | 129 | 44.94% | 49 | - |
| Mar 31, 2024 | 161 | 9.52% | 89,302,004 | 17.64% | 102 | 0.95% | 89 | 14.10% | 49 | 6.52% |
| Dec 31, 2023 | 147 | 2.08% | 75,911,779 | -7.12% | 103 | 0.85% | 78 | -2.50% | 46 | 17.95% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl S | 5.07M | 4.22% | 7.37K |
| Fidelity Growth Compy Commingled Pl O | 4.86M | 4.11% | -69.00K |
| US Small-Cap Growth II Equity Comp | 4.43M | 3.69% | 6.93K |
| T. Rowe Price New Horizons | 4.43M | 3.69% | -59.97K |
| Vanguard Total Stock Mkt Idx Inv | 3.58M | 2.98% | 13.44K |
| Vanguard US Total Market Shares ETF | 3.53M | 2.93% | 3.12K |
| Fidelity Growth Company Fund | 3.49M | 2.90% | - |
| iShares Russell 2000 ETF | 2.99M | 2.48% | -25.85K |
| T. Rowe Price Health Sciences | 2.42M | 2.01% | -76.44K |
| Vanguard Health Care Inv | 2.35M | 1.97% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 01, 2025 | Gallagher Kathleen P. | Chief Program Officer | Sell | $9.16K |
| Mar 20, 2025 | Hughes Steven George | Chief Medical Officer | Sell | $297.49K |
| Mar 20, 2025 | Boyce Sarah | President and CEO | Sell | $979.56K |
| Mar 20, 2025 | Flanagan W. Michael | Chief Scientific Officer | Sell | $365.87K |
| Mar 20, 2025 | MacLean Michael F | Chief Financial Officer | Sell | $246.42K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q2 | - | 1 |
| 2025 Q1 | - | 23 |
| 2024 Q4 | - | 14 |
| 2024 Q3 | - | 14 |
| 2024 Q2 | - | 18 |
RNA Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools